JTCS Click here to go to SJM website.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Daniel Y. Loisance
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kirsch, E.W. M.
Right arrow Articles by Loisance, D. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kirsch, E.W. M.
Right arrow Articles by Loisance, D. Y.

J Thorac Cardiovasc Surg 2006;132:1010-1016
© 2006 The American Association for Thoracic Surgery


Surgery for Acquired Cardiovascular Disease

Heterogeneity in the remodeling of aneurysms of the ascending aorta with tricuspid aortic valves

E.W. Matthias Kirsch, MD, PhDa,b,*, N. Costin Radu, MDa,b, Marianne Gervais, PhDa, Eric Allaire, MD, PhDa,c, Daniel Y. Loisance, MDa,b

a Surgical Research Center, Paris XII University, IFR de Médecine, Hôpital Henri Mondor, Créteil, France
b Chirurgie Thoracique et Cardiovasculaire, Hôpital Henri Mondor, Créteil, France
c Vascular Surgery Department, Hôpital Henri Mondor, Créteil, France.

Received for publication January 30, 2006; accepted for publication April 24, 2006.

* Address for reprints: Matthias Kirsch, MD, PhD, Department of Cardiothoracic Surgery, Hospital Henri Mondor, 51 Avenue Mal de Lattre de Tassigny, 94 000 Créteil Cedex, France. (Email: matthias.kirsch{at}hmn.aphp.fr).

OBJECTIVES: The study addresses mechanisms driving the formation of ascending aortic aneurysms by comparing the maximal dilatation area with the transition area immediately adjacent to the normal aortic tissue left in place during surgical repair.

METHODS: Aortic wall specimens were taken from the maximal dilatation area and transition area in 10 patients undergoing surgery for ascending aortic aneurysms and fixed for histology and immunohistochemistry for vascular smooth muscle cells (alpha-actin), endothelial cells (CD31), and macrophages (CD68). Tissue concentrations of vascular endothelial growth factor, matrix metalloproteinase-2, and matrix metalloproteinase-9 were determined by enzyme-linked immunosorbent assay. The results are expressed as medians with their 25th and 75th centiles.

RESULTS: Vascular smooth muscle cells were significantly more abundant in the maximal dilatation area than in the transition area (20.3 [14.8-24.4]/10–2 mm2 vs 8.0 [6.4-9.3]/10–2 mm2, respectively, P = .002). In the maximal dilatation area, vascular smooth muscle cells had lost their typical lamellar organization, whereas it was preserved in the transition area. Microvessels were significantly more abundant in the media of transition area than in the maximal dilatation area (7.5 [2.9-10.1]/mm2 vs 1.75 [1.5-2.0]/mm2, respectively, P = .008) and were associated with an inflammatory cell infiltration that predominated in their immediate vicinity. There were no significant differences in vascular endothelial growth factor, matrix metalloproteinase-2, and matrix metalloproteinase-9 between both areas.

CONCLUSIONS: The transition area appears as a disease progression front characterized by microvessel formation and inflammatory cell infiltration. In contrast, increased vascular smooth muscle cell density in the maximal dilatation area suggests a healing process, although inefficient to prevent aortic dilatation.



Abbreviations and Acronyms AAA = abdominal aortic aneurysm; AsAA = ascending aortic aneurysm; MDA = maximal dilatation area; MMP = matrix metalloproteinase; TA = transition area; VEGF = vascular endothelial growth factor; VSMC = vascular smooth muscle cell





This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
I. K. Toumpoulis, J. T. Oxford, D. B. Cowan, C. E. Anagnostopoulos, C. K. Rokkas, T. P. Chamogeorgakis, D. C. Angouras, R. J. Shemin, M. Navab, M. Ericsson, et al.
Differential expression of collagen type V and XI alpha-1 in human ascending thoracic aortic aneurysms.
Ann. Thorac. Surg., August 1, 2009; 88(2): 506 - 513.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. Della Corte, C. Quarto, C. Bancone, C. Castaldo, F. Di Meglio, D. Nurzynska, L. S. De Santo, M. De Feo, M. Scardone, S. Montagnani, et al.
Spatiotemporal patterns of smooth muscle cell changes in ascending aortic dilatation with bicuspid and tricuspid aortic valve stenosis: Focus on cell matrix signaling
J. Thorac. Cardiovasc. Surg., January 1, 2008; 135(1): 8 - 18.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2006 by The American Association for Thoracic Surgery.